Literature DB >> 9742365

Pharmacologic therapy for urinary incontinence and voiding dysfunctions.

S G Portera1, G H Lipscomb.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9742365     DOI： 10.1097/00003081-199809000-00025

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


× No keyword cloud information.
  4 in total

Review 1.  Pharmacological therapy of female urinary incontinence.

Authors:  Diaa E E Rizk
Journal:  Afr Health Sci       Date:  2005-03       Impact factor: 0.927

Review 2.  Extended-release oxybutynin.

Authors:  A M Comer; K L Goa
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

3.  Transdermal oxybutynin: for overactive bladder.

Authors:  Lynne M Bang; Stephanie E Easthope; Caroline M Perry
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin.

Authors:  Tondalaya Gamble; Peter Sand
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.